Trials / Completed
CompletedNCT01655862
A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA
Multi-Centre, Prospective, Observational Study of Patient Reported Outcomes in Patients Diagnosed With Cervical Dystonia and Treated With OnabotulinumtoxinA for Injection (BOTOX®) (POSTURe)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 62 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study to assess health-related quality of life in patients with cervical dystonia (dystonie) treated with OnabotulinumtoxinA per routine clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | OnabotulinumtoxinA | OnabotulinumtoxinA injections at doses and frequencies as determined by the physician in accordance with clinical practice. |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2012-08-02
- Last updated
- 2017-03-30
Locations
8 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01655862. Inclusion in this directory is not an endorsement.